Your browser doesn't support javascript.
loading
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.
Scherpereel, Arnaud; Antonia, Scott; Bautista, Yolanda; Grossi, Francesco; Kowalski, Dariusz; Zalcman, Gérard; Nowak, Anna K; Fujimoto, Nobukazu; Peters, Solange; Tsao, Anne S; Mansfield, Aaron S; Popat, Sanjay; Sun, Xiaowu; Lawrance, Rachael; Zhang, Xiaoqing; Daumont, Melinda J; Bennett, Bryan; McKenna, Mike; Baas, Paul.
Affiliation
  • Scherpereel A; Pulmonary and Thoracic Oncology Department, University of Lille, CHU Lille, INSERM, OncoThAI, Institut Coeur Poumon, Boulevard du Professeur Jules Leclercq, 59037 Lille, France. Electronic address: arnaud.scherpereel@chru-lille.fr.
  • Antonia S; Thoracic Oncology Department, H. Lee Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA. Electronic address: scott.antonia@duke.edu.
  • Bautista Y; Centro Médico Nacional Siglo XXI, Av. Cuauhtémoc 330, Doctores, Cuauhtémoc, 06720 Mexico City, Mexico. Electronic address: ybautista@invesclinic.com.
  • Grossi F; UOS Tumori Polmonari, Largo Rosanna Benzi, 10, 16132 Genova, Italy. Electronic address: fg1965@libero.it.
  • Kowalski D; Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska 15 B, 00-001 Warsaw, Poland. Electronic address: dariusz.kowalski@coi.pl.
  • Zalcman G; Thoracic Oncology Department, Université de Paris, 17 Rue Jean Antoine de Baïf, 75013 Paris, France. Electronic address: gerard.zalcman@aphp.fr.
  • Nowak AK; Medical School, University of Western Australia and Sir Charles Gairdner Hospital, 35 Stirling Highway, 6009 Perth, Australia. Electronic address: anna.nowak@uwa.edu.au.
  • Fujimoto N; Medical Oncology, Okayama Rosai Hospital, 1 Chome-10-25 Chikkomidorimachi, Minami Ward, Okayama, Japan. Electronic address: nobufujimot@gmail.com.
  • Peters S; Oncology Department, Lausanne University Hospital, Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.
  • Tsao AS; Department of Thoracic-Head & Neck Medical Oncology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: astsao@mdanderson.org.
  • Mansfield AS; Medical Oncology, Mayo Clinic, 200 First St., SW, Rochester, MN 55905, USA. Electronic address: Mansfield.Aaron@mayo.edu.
  • Popat S; Lung Unit, Royal Marsden Hospital, London, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: Sanjay.Popat@rmh.nhs.uk.
  • Sun X; Adelphi Values, 290 Congress St., Boston, MA 02210, USA. Electronic address: xiaowu.sun@adelphivalues.com.
  • Lawrance R; Adelphi Values, 290 Congress St., Boston, MA 02210, USA. Electronic address: rachael.lawrance@adelphivalues.com.
  • Zhang X; Bristol Myers Squibb, 3551 Lawrenceville Rd., Princeton, NJ 08540, USA. Electronic address: Xiaoqing.Zhang@bms.com.
  • Daumont MJ; Bristol Myers Squibb, Avenue de Finlande 4, 1420 Braine-l'Alleud, Belgium. Electronic address: Melinda.Daumont@bms.com.
  • Bennett B; Bristol Myers Squibb, Sanderson Rd., Uxbridge UB8 1DH, UK. Electronic address: Bryan.Bennett@bms.com.
  • McKenna M; Health Outcomes Solutions, Radius House, 51 Clarendon Road, Watford WD17 1HP, UK. Electronic address: mike@healthoutcomes.co.uk.
  • Baas P; Department of Thoracic Oncology, The Netherlands Cancer Institute and Leiden University Medical Center, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. Electronic address: p.baas@nki.nl.
Lung Cancer ; 167: 8-16, 2022 05.
Article in En | MEDLINE | ID: mdl-35367910

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Ireland